Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer

被引:67
|
作者
Diez, M
Torres, A
Maestro, ML
Ortega, MD
Gomez, A
Pollan, M
Lopez, JA
Picardo, A
Hernando, F
Balibrea, JL
机构
[1] UNIV MADRID, SAN CARLOS HOSP, MADRID 3, SPAIN
[2] INST SALUD CARLOS 3, NATL CTR EPIDEMIOL, CANC EPIDEMIOL UNIT, MADRID, SPAIN
关键词
carcinoembryonic antigen; CA125; squamous cell carcinoma antigen; lung cancer; prognostic factor; survival;
D O I
10.1038/bjc.1996.239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect to TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power. but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.
引用
收藏
页码:1248 / 1254
页数:7
相关论文
共 50 条
  • [1] Concordance between serum and cytosolic levels of CEA CA125 and SCC antigens in patients with non-small cell lung cancer
    Diez, M
    Pollan, M
    Maestro, ML
    Ortega, MD
    Gomez, A
    SanchezPernaute, A
    Torres, A
    Granell, J
    Balibrea, JL
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2811 - 2817
  • [2] RELATIONSHIP BETWEEN SERUM AND CYTOSOLIC CONCENTRATIONS OF CEA, CA125 AND SCC ANTIGENS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
    DIEZ, M
    ORTEGA, MD
    MAESTRO, ML
    TORRES, A
    GOMEZ, A
    HERNANDO, F
    DELREAL, A
    BALIBREA, JL
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1994, 9 (04): : 25 - 30
  • [3] Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer
    Gaspar, MJ
    Diez, M
    Rodriguez, A
    Ratia, T
    Duce, AM
    Galvan, M
    Granell, J
    Coca, C
    ANTICANCER RESEARCH, 2003, 23 (04) : 3427 - 3432
  • [4] EVALUATION OF SERUM CA125 AS A TUMOR-MARKER IN NON-SMALL-CELL LUNG-CANCER
    DIEZ, M
    CERDAN, FJ
    ORTEGA, MD
    TORRES, A
    PICARDO, A
    BALIBREA, JL
    CANCER, 1991, 67 (01) : 150 - 154
  • [5] Tumour-associated antigens CEA, CA125, SCC and TPS in gynaecological cancer
    Sarandakou, A
    Phocas, I
    Botsis, D
    Sikiotis, K
    Rizos, D
    Kalambokis, D
    Trakakis, E
    Chryssikopoulos, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (01) : 73 - 77
  • [6] Preoperative serum CA125 as an independent predictor for recurrence and death in operable patients with non-small cell lung cancer
    Feng, Jianguo
    Xu, Haiyan
    Wu, Hanmo
    Luo, Min
    Mao, Weimin
    Su, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer
    Salgia, R
    Harpole, D
    Herndon, JE
    Pisick, E
    Elias, A
    Skarin, AT
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1241 - 1246
  • [8] SERUM TUMOR MARKERS CEA, CYFRA AND CA125 ARE ASSOCIATED WITH WORSE PROGNOSIS IN ADVANCED NON- SMALL CELL LUNG CANCER (NSCLC)
    Cedres, S.
    Nunez, I.
    Longo, M.
    Martinez, P.
    Checa, E.
    Rodriguez-Freixinos, V.
    Serrano, C.
    Felip, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 131 - 131
  • [9] CEA, CYFRA21-1 AND SCC IN NON-SMALL-CELL LUNG-CANCER
    MORO, D
    VILLEMAIN, D
    VUILLEZ, JP
    DELORD, CA
    BRAMBILLA, C
    LUNG CANCER, 1995, 13 (02) : 169 - 176
  • [10] Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer
    Sok, Mihael
    Ravnik, Janez
    Ravnik, Maja
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (9-10) : 314 - 317